Risk-Benefit Analysis in Drug Research: Proceedings of an International Symposium held at the University of Kent at Canterbury, England, 27 March 1980
Editat de J.F. Cavallaen Limba Engleză Paperback – 4 aug 2012
Preț: 345.84 lei
Preț vechi: 364.05 lei
-5% Nou
Puncte Express: 519
Preț estimativ în valută:
66.19€ • 70.28$ • 54.83£
66.19€ • 70.28$ • 54.83£
Carte tipărită la comandă
Livrare economică 25 decembrie 24 - 08 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789401571340
ISBN-10: 9401571341
Pagini: 208
Ilustrații: 197 p. 7 illus.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.3 kg
Ediția:Softcover reprint of the original 1st ed. 1981
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9401571341
Pagini: 208
Ilustrații: 197 p. 7 illus.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.3 kg
Ediția:Softcover reprint of the original 1st ed. 1981
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
1 Risk—benefit in medicine.- 2 The effect on industry.- 3 The effect on the public.- Discussion of Chapters 2 and 3.- 4 The necessary role of government.- 5 Problems facing a regulatory authority.- Discussion of Chapters 4 and 5.- 6 The effect on pharmaceutical research.- 7 New-drug assessment in man: a clinical pharmacologist’s view.- Discussion of Chapters 6 and 7.- 8 The effect on choice of research.- 9 The relative worth of animal testing.- 10 The prospect of product liability.- Discussion of Chapters 9 and 10.- 11 The effect on world medicine.- 12 Preclinical requirements.- 13 Post-marketing drug surveillance.- Discussion of Chapters 12 and 13.- 14 The influence of the media.- Discussion of Chapter 14.- 15 The influence of the medical profession.- Summary and conclusions.